Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers

BACKGROUND: Approximately two thirds of patients with localized triple-negative breast cancer (TNBC) harbor residual disease (RD) after neoadjuvant chemotherapy (NAC) and have a high risk-of-recurrence. Targeted therapeutic development for TNBC is of primary significance as no targeted therapies are...

Descripción completa

Detalles Bibliográficos
Autores principales: Hancock, Bradley A., Chen, Yu-Hsiang, Solzak, Jeffrey P., Ahmad, Mufti N., Wedge, David C., Brinza, Dumitru, Scafe, Charles, Veitch, James, Gottimukkala, Rajesh, Short, Walt, Atale, Rutuja V., Ivan, Mircea, Badve, Sunil S., Schneider, Bryan P., Lu, Xiongbin, Miller, Kathy D., Radovich, Milan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683504/
https://www.ncbi.nlm.nih.gov/pubmed/31383035
http://dx.doi.org/10.1186/s13058-019-1171-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683504/
https://www.ncbi.nlm.nih.gov/pubmed/31383035
http://dx.doi.org/10.1186/s13058-019-1171-7

Ejemplares similares